title: Timing is everything: Targeting IgE to reduce asthma exacerbation risk.
authors.affiliation: Firestone Institute of Respiratory Health and the Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: obyrnep@mcmaster.ca.
authors.forename: Paul M
authors.initials: PM
authors.lastname: O'Byrne
authors.affiliation: Firestone Institute of Respiratory Health and the Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada; Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.
authors.forename: Damian
authors.initials: D
authors.lastname: Tworek
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D004334:Drug Administration Schedule; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D000069444:Omalizumab / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D018927:Anti-Asthmatic Agents; D000069444:Omalizumab; D007073:Immunoglobulin E
keywords: Inhaled corticosteroids; anti-IgE; asthma exacerbations